In 2022, pharmaceutical sales of drugs for the alimentary tract and metabolism reached a value of 87.6 U.S. dollars per person in South Korea. This was above the 2021 OECD average of 66.4 dollars per person. Consumption by sales value was above OECD average in most anatomical main groups, with the exception of drugs for the nervous system, the respiratory system, and hormones.
Value of level 1 ATC pharmaceutical drugs consumed in South Korea in 2022, compared to 2021 OECD average
(in U.S. dollars per person)
Adjust the presentation of the statistic and data points.
Share the statistic on social media channels or embed the statistic in your
website using "Embed Code", where available.
Cite this statistic and select one of the following formats: APA, Chicago, Harvard, MLA & Bluebook.
Print the statistic including description and metadata.
Chart type
Value of level 1 ATC pharmaceutical drugs consumed in South Korea in 2022, compared to 2021 OECD average
Share this statistic
You have no right to use this feature.
Make sure to contact us if you are interested in scientific citation.
You can upgrade your account to enable this functionality for all statistics.
This feature is not available with your current account.Request access
* Includes dermatologicals (D), antineoplastic and immunomodulating agents (L), antiparasitic products, insecticides and repellents (P), sensory organs (S), and various (V).
Sales value includes additional fees such as preparation fees.
Statista has been my savior on several occasions.
The site is easy to maneuver and the data is in a format that can
go right into a report or presentation.
Learn more about how Statista can support your business.
MOHW (South Korea). (March 28, 2024). Value of level 1 ATC pharmaceutical drugs consumed in South Korea in 2022, compared to 2021 OECD average (in U.S. dollars per person) [Graph]. In Statista. Retrieved February 18, 2025, from https://www.statista.com/statistics/1446528/south-korea-level-1-pharmaceuticals-value-taken-compared-to-oecd/
MOHW (South Korea). "Value of level 1 ATC pharmaceutical drugs consumed in South Korea in 2022, compared to 2021 OECD average (in U.S. dollars per person)." Chart. March 28, 2024. Statista. Accessed February 18, 2025. https://www.statista.com/statistics/1446528/south-korea-level-1-pharmaceuticals-value-taken-compared-to-oecd/
MOHW (South Korea). (2024). Value of level 1 ATC pharmaceutical drugs consumed in South Korea in 2022, compared to 2021 OECD average (in U.S. dollars per person). Statista. Statista Inc.. Accessed: February 18, 2025. https://www.statista.com/statistics/1446528/south-korea-level-1-pharmaceuticals-value-taken-compared-to-oecd/
MOHW (South Korea). "Value of Level 1 Atc Pharmaceutical Drugs Consumed in South Korea in 2022, Compared to 2021 Oecd Average (in U.S. Dollars per Person)." Statista, Statista Inc., 28 Mar 2024, https://www.statista.com/statistics/1446528/south-korea-level-1-pharmaceuticals-value-taken-compared-to-oecd/
MOHW (South Korea), Value of level 1 ATC pharmaceutical drugs consumed in South Korea in 2022, compared to 2021 OECD average (in U.S. dollars per person) Statista, https://www.statista.com/statistics/1446528/south-korea-level-1-pharmaceuticals-value-taken-compared-to-oecd/ (last visited February 18, 2025)
Value of level 1 ATC pharmaceutical drugs consumed in South Korea in 2022, compared to 2021 OECD average (in U.S. dollars per person) [Graph], MOHW (South Korea), March 28, 2024. [Online]. Available: https://www.statista.com/statistics/1446528/south-korea-level-1-pharmaceuticals-value-taken-compared-to-oecd/
Profit from additional features with an Employee Account
Please create an employee account to be able to mark statistics as favorites.
Then you can access your favorite statistics via the star in the header.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.